No real surprises in the report.
It is clear that this is all about where they head over the next 12 months.
Good to see some costs have come down as expected. Reading into the details it is really still early days for id8
R3 trial appears to be still going to happen where ID8 will test the platform with Tier 1 banks under a Trial it has been delayed until next year.
As previously mentioned the problem that they are solving is one that will be faced by many banks over the coming months and years.
The fact that HSBC has engaged Id8 to start here in Australia following up from India. It is just a shame it has been delayed, did mention an Audit so that could be progressing in the coming months to go live. But no set date.
MasterCard would of done DD and has identified ID8 as solving problems internally. This is a vote of confidence for the wider market and will only assist in sales opportunities.
Where they really need to come to the party is how they sell themselves to 'investors'. If they can work on that once they sign a few more deals this will really pickup some momentum.
In terms of what ID8 is worth it is challenging one. I would think based on the progress to date we are probably looking in that 25 to 35 range imo.
Good to note we doubled investors holding stock with over 800 this year compared to last.
If you believe in the company and are patient, this could really be a 5 to 10 X opportunity in the coming 12 to 24 months. In regards to the discussion around capital they did indicate they will be reviewing that over the coming months.
Happy to hear what others thought.
DYOR-
Status- Long term Holder
- Forums
- ASX - By Stock
- ID8
- Ann: Annual Report
Ann: Annual Report, page-6
-
- There are more pages in this discussion • 29 more messages in this thread...
You’re viewing a single post only. To view the entire thread just sign in or Join Now (FREE)
Featured News
Add ID8 (ASX) to my watchlist
(20min delay)
|
|||||
Last
2.4¢ |
Change
0.006(33.3%) |
Mkt cap ! $15.61M |
Open | High | Low | Value | Volume |
1.8¢ | 2.4¢ | 1.8¢ | $145.1K | 6.852M |
Buyers (Bids)
No. | Vol. | Price($) |
---|---|---|
1 | 50000 | 2.3¢ |
Sellers (Offers)
Price($) | Vol. | No. |
---|---|---|
2.6¢ | 247000 | 2 |
View Market Depth
No. | Vol. | Price($) |
---|---|---|
1 | 50000 | 0.023 |
2 | 350000 | 0.022 |
1 | 70745 | 0.021 |
1 | 318617 | 0.020 |
2 | 183000 | 0.019 |
Price($) | Vol. | No. |
---|---|---|
0.026 | 247000 | 2 |
0.027 | 180000 | 2 |
0.028 | 285000 | 2 |
0.029 | 370000 | 1 |
0.032 | 400000 | 1 |
Last trade - 16.10pm 12/11/2024 (20 minute delay) ? |
Featured News
ID8 (ASX) Chart |
The Watchlist
NUZ
NEURIZON THERAPEUTICS LIMITED
Michael Thurn, CEO & MD
Michael Thurn
CEO & MD
Previous Video
Next Video
SPONSORED BY The Market Online